Whereas previous studies have shown an association between tumour mutation burden and survival both independently [20] and in relation to other somatic mutations, e.g. BRAF mutations [21], our data indicates that the TMB status and tumour histopathology features are highly correlated, and that TMB status does not significantly associate with survival when adjusted for them. This evidence concerns the gene BRAF and neoplasm.